Products
Online Inquiry
MK-4409
Cat. No.:
OB0225WX-2201
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
MK-4409 is a novel oxazole-based small molecule that functions as a selective inhibitor of fatty acid amide hydrolase (FAAH).
Synonym:
MK4409;MK 4409; 1207745-58-1; 2-[5-[5-(5-chloropyridin-2-yl)sulfanyl-2-(4-fluorophenyl)-1,3-oxazol-4-yl]pyridin-2-yl]propan-2-ol; 2-Pyridinemethanol, 5-(5-((5-chloro-2-pyridinyl)thio)-2-(4-fluorophenyl)-4-oxazolyl)-alpha,alpha-dimethyl-; 2-Pyridinemethanol, 5-[5-[(5-chloro-2-pyridinyl)thio]-2-(4-fluorophenyl)-4-oxazolyl]-alpha,alpha-dimethyl-; 5-(5-((5-Chloro-2-pyridinyl)thio)-2-(4-fluorophenyl)-4-oxazolyl)-alpha,alpha-dimethyl-2-pyridinemethanol
CAS No.:
1207745-58-1
Compound CID:
53341130
Formula:
C22H17ClFN3O2S
Formula Weight:
441.91
Specification
Relative Density:
1.44 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
MK-4409 is utilized in inflammatory research as a potent and selective p38 alpha MAPK inhibitor to investigate the suppression of cytokine production and the modulation of stress-activated signaling pathways.
Library Information
Target:
FAAH
Receptor:
FAAH
Pathways:
Metabolism; Neuronal signaling
Plate Number:
AOCL-29
Plate Location:
b6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
